arrow
C

Chiara Mazzarelli

Asst Grande Ospedale Metropolitano Niguarda
H指数:17
被引数:1,807

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stratifying Cardiovascular Risk in Patients With HCC Receiving Atezolizumab/Bevacizumab: A Comparison of ESC and CARDIOSOR Scores

在采用阿替利珠单抗/贝伐珠单抗治疗的肝癌患者中分层心血管风险:ESC评分与CARDIOSOR评分的比较

2026-10-070
OAAI
MRI-Derived Evaluation of Liver Function and Its Extension to K-Edge Photon-Counting CT: Focus on Gadolinium-Based Functional Biliary Imaging

MRI衍生肝功能评估及其在K边光子计数CT中的应用扩展:聚焦于钆基功能性胆道成像

2026-08-310
OA
Durvalumab–Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data From the LOR-HCC (Lombardy Real-World HCC Group)

度伐鲁单抗–曲美木单抗在晚期肝细胞癌中的应用:来自LOR-HCC(伦巴第真实世界HCC研究组)的真实世界数据

2026-04-160
OAAI
Radiomics-Based Prognostication in Primary Sclerosing Cholangitis: A Proof-of-Concept Study

基于放射组学的原发性硬化性胆管炎预后预测:一项概念验证研究

2025-09-270
OAAI
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab

丙型肝炎清除可改善接受阿替利珠单抗联合贝伐珠单抗治疗患者的肿瘤学和临床结局

2025-09-220
PREAI
Association between sustained virological response and adverse liver-related events in patients with decompensated HCV cirrhosis

持续病毒学应答与失代偿期HCV肝硬化患者不良肝脏相关事件之间的关联

2025-09-150
PREAI
Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono-Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study

乙型肝炎免疫球蛋白停用在乙型肝炎病毒单感染肝移植受者中的研究:一项意大利多中心前瞻性研究

2025-08-270
OAAI
The changing scenario in hepatocellular carcinoma management: the Niguarda experience
2025-03-010
PRE
Liver Transplantation in Alcohol-Associated Hepatitis. Benefits and Limitations of Psychosocial Selection and Support in Alcohol Relapse. The Experience of a Tertiary Center in Italy

酒精性肝炎的肝移植。心理社会选择和支持在酒精复饮中的益处与局限性。意大利一家三级医疗中心的经验。

2025-01-060
OA
Trends in liver transplantation for primary sclerosing cholangitis
2024-08-013
PRE
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study
2024-07-060
OAAI
TKIs treatment for HCC before Liver transplantation: an ELITA/ELTR collaborative study
2024-02-010
OAAI
Efficacy and safety of lusutrombopag in a real-world Italian series of cirrhotic patients with severe thrombocytopenia undergoing invasive procedures: the Reality study
2024-02-010
PRE